Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Medicinova Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 40 | 34 | −6 |
| Shares | 5.59M | 5.38M | −206.6K (−3.7%) |
| Value | $12.1M | $12.4M | +$325.7K (+2.7%) |
New holders (2)
Institutions that held Medicinova Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 127,300 | $310.6K | 0.00% |
| Royal Bank of Canada | 289 | $1.00K | 0.00% |
Sold out (8)
Institutions that held Medicinova Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Jane Street Group, LLC | 52,223 | $112.8K |
| Susquehanna International Group, LLP | 32,180 | $69.5K |
| Capricorn Fund Managers Ltd | 25,379 | $54.8K |
| Goldman Sachs Group Inc | 22,702 | $49.0K |
| Blankinship & Foster, LLC | 15,700 | $33.9K |
| ExodusPoint Capital Management, LP | 14,157 | $31.0K |
| Point72 Asset Management, L.P. | 7,675 | $16.6K |
| Cubist Systematic Strategies, LLC | 3,476 | $7.51K |